-transparent.png){kind=logo}
A patient relapsing with blastic lymphoid transformation of chronic myeloid leukemia after bone marrow transplantation received donor buffy-coat infusion. Low-dose chemotherapy was added because of a rapid WBC increase. Complete hematologic and cytogenetic remission was obtained. The patient remained in complete hematologic and cytogenetic remission for four months until he died in an accident. Two patients with acute leukemia failed to respond to a similar treatment.
Related Publications
V Bogdanić, and
I Aurer, and
V Hitrec, and
D Boban, and
D Nemet, and
S Zupancić-Salek, and
B Labar
September 1988,
Blood,
V Bogdanić, and
I Aurer, and
V Hitrec, and
D Boban, and
D Nemet, and
S Zupancić-Salek, and
B Labar
November 1993,
Transplantation,
V Bogdanić, and
I Aurer, and
V Hitrec, and
D Boban, and
D Nemet, and
S Zupancić-Salek, and
B Labar
January 1996,
Haematologica,
V Bogdanić, and
I Aurer, and
V Hitrec, and
D Boban, and
D Nemet, and
S Zupancić-Salek, and
B Labar
June 2010,
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
V Bogdanić, and
I Aurer, and
V Hitrec, and
D Boban, and
D Nemet, and
S Zupancić-Salek, and
B Labar
March 1981,
The New England journal of medicine,
V Bogdanić, and
I Aurer, and
V Hitrec, and
D Boban, and
D Nemet, and
S Zupancić-Salek, and
B Labar
April 2001,
Pediatrics international : official journal of the Japan Pediatric Society,
V Bogdanić, and
I Aurer, and
V Hitrec, and
D Boban, and
D Nemet, and
S Zupancić-Salek, and
B Labar
March 1999,
Bone marrow transplantation,
V Bogdanić, and
I Aurer, and
V Hitrec, and
D Boban, and
D Nemet, and
S Zupancić-Salek, and
B Labar
February 1993,
Bone marrow transplantation,
V Bogdanić, and
I Aurer, and
V Hitrec, and
D Boban, and
D Nemet, and
S Zupancić-Salek, and
B Labar
February 1982,
Blood,
V Bogdanić, and
I Aurer, and
V Hitrec, and
D Boban, and
D Nemet, and
S Zupancić-Salek, and
B Labar
March 2004,
Bone marrow transplantation,
